A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT03474081 · COMPLETED
Trial details
- NCT number
- NCT03474081
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-29
- Primary completion
- 2019-07-17
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.